Managed Healthcare Executive20h
MedImpact Adds the Biosimilars Selarsdi and Yesintek to Formulary
Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...
centerforbiosimilars1h
The Top 5 Biosimilar Articles for the Week of February 24
Number 4: Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept ...
Managed Healthcare Executive23h
BC of Michigan Adds — and Drops — Step Edits for Darzalex Faspro
Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro ...
STAT16h
Trump is looking for drugmakers to come through for him. They have a wish list for him, too
After announcing plans to build four manufacturing sites in the U.S. on Wednesday, Eli Lilly CEO Dave Ricks skillfully ...
Key Themes, Strategic Moves, and Market Dynamics from JP Morgan's 43rd Annual Healthcare Conference, January 13-16, 2025
The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's offering.The 43rd Annual JP Morgan Healthcare Conference took place in San ...